Results 91 to 100 of about 29,949 (204)

Effectiveness of enoxaparin in preventing intraoperative fibrin formation during DMEK assessed in a before-and-after study

open access: yesScientific Reports
To demonstrate that enoxaparin in the irrigation saline solution can effectively prevent intraoperative fibrin formation (IFF) during Descemet membrane endothelial keratoplasty (DMEK) surgery without compromising graft viability, visual recovery, or ...
Pablo De-Arriba-Palomero   +9 more
doaj   +1 more source

Inhibition of PAR-1 receptor signaling by enoxaparin reduces cell proliferation and migration in A549 cells

open access: yes, 2019
Background/Aim: Low-molecular weight heparins (LMWHs) may possess putative antitumoral properties; however, the underlying mechanism(s) remains elusive.
Alturkistani, Azhaar   +4 more
core   +1 more source

Consumption pattern of enoxaparin in a non-teaching hospital (a cross-sectional prospective study)

open access: yesJournal of Pharmacoeconomics and Pharmaceutical Management, 2022
Background: Drug use evaluation studies are conducted to assess the pattern of prescribing and administration of a drug. Deep vein thrombosis is one of the most important clinical issues around the world.
Mohammadreza Rafati   +3 more
doaj  

Meta regression analysis to indirectly compare dalteparin to enoxaparin for the prevention of venous thromboembolic events following total hip replacement

open access: yesThrombosis Journal, 2011
Background Patients undergoing elective total hip replacement (THR) surgery are at an increased risk for venous thromboembolic events (VTEs). Dalteparin and enoxaparin are recommended as thromboprophylaxis for at least 10 days in these patients.
Choe Yoonhee   +2 more
doaj   +1 more source

Influence of low molecular weight heparins on immune system of surgical patients

open access: yesPerioperative Medicine, 2019
Venous thromboembolic complications are potentially dangerous complications to life in patients undergoing surgical intervention. The aim of the work is to study the safety of enoxaparin thromboprophylaxis by eliciting the effect of sodium enoxaparin (
O O Budnyuk   +4 more
doaj   +1 more source

Characterization of PCL and Chitosan Nanoparticles as Carriers of Enoxaparin and Its Antithrombotic Effect in Animal Models of Venous Thrombosis

open access: yesJournal of Nanotechnology, 2017
This study was based on the preparation, characterization, and animal in vivo experiments performed to evaluate nanoparticles of poly(ɛ-caprolactone) (PCL) and chitosan as carriers of enoxaparin.
Lucas Bessa Prado   +6 more
doaj   +1 more source

The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients

open access: yes, 2012
Graham F Pineo1, Jay Lin2, Lieven Annemans31Department of Medicine, University of Calgary, Calgary, Alberta, Canada; 2Novosys Health, Flemington, NJ; 3Department of Medicine, Ghent University, Ghent and Brussels University, Brussels, BelgiumAbstract ...
Pineo GF, Annemans L, Lin J
core  

Throbbing headache associated with enoxaparin administration : a case report, a review of pharmacovigilance databases for similar cases and possible mechanisms

open access: yes, 2015
To date, no case of headache has been reported with enoxaparin. We present the case of a 60-years-old man, who developed enoxaparin-induced throbbing headache and discuss the possible pharmacological mechanisms.
P. Pellegrino   +10 more
core   +1 more source

Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin for Venous Thromboembolism Prophylaxis in Hemodialysis Patients

open access: yes, 2017
Background: Enoxaparin, a low-molecular-weight heparin approved for prophylaxis in patients at risk for venous thromboembolism (VTE), offers several advantages compared with unfractionated heparin (UFH).
Amanda R. Buckallew   +2 more
core   +1 more source

Non-Anticoagulant Oligosaccharides of Enoxaparin Relieve Chemical-Induced Acute Colitis

open access: yes, 2016
Enoxaparin, a low molecular weight heparin, is commonly used for the treatment and prophylaxis of thromboembolic disorders. Apart from its anticoagulant properties, enoxaparin is known to possess anti-inflammatory activities and therefore could ...
Lean, QY (15578453)   +4 more
core  

Home - About - Disclaimer - Privacy